Healthcare & Life Sciences
NRx Pharmaceuticals
United Stateswww.nrxpharma.com/
NRx Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About NRx Pharmaceuticals
NRx Pharmaceuticals is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
NRx Pharmaceuticals is a clinical biopharmaceutical company developing treatments focused on severe bipolar depression, suicidality, and PTSD, with lead investigational therapies NRX-100 (ketamine) and NRX-101 currently in FDA clinical trials.
Explore NRx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.